3/29/2024 | 300215000000 | MK-3475 25 MG/ML STERILE SOLUTION IS FOR CLINICAL RESEARCH PURPOSES. IT IS NOT IN THE SCOPE OF 2024/16-19 NOTIFICATION.+ | XXXXXXXXXX | 32 | UNIT | 58203 | IRELAND | NA |
3/29/2024 | 300215000000 | PF-06863135 (ELRANATAMAB) SOLUTION FOR I/NJECTION 40MG/ML VIAL | XXXXXXXXXX | 2 | UNIT | 560 | USA | NA |
3/29/2024 | 300215000000 | PF-06863135 (ELRANATAMAB) SOLUTION FOR I/NJECTION 40MG/ML VIAL | XXXXXXXXXX | 6 | UNIT | 1682 | BELGIUM | NA |
3/28/2024 | 300215000000 | PEMBROLIZUMAB 25 MG/ML SOLUTION FOR INFU/SION (100 MG/4 ML) | XXXXXXXXXX | 30 | UNIT | 28170 | IRELAND | NA |
3/27/2024 | 300215000000 | ;VIALS RAVULIZUMAB CONCENTRATE FOR SOLUTION FOR INF (WILL BE USED FOR RESEARCH AND ANALYSIS IN THE LABORATORY) | XXXXXXXXXX | 3 | UNIT | 51 | SPAIN | NA |
3/27/2024 | 300215000000 | MK-3475 25 MG/ML SOLUTION 4 ML IS FOR CLINICAL RESEARCH PURPOSES. IT IS NOT IN THE SCOPE OF 2024/16-19 NOTIFICATION.+ | XXXXXXXXXX | 72 | UNIT | 126775 | IRELAND | NA |
3/27/2024 | 300215000000 | MK-4280A 20/5 MG/ML/ MK-3475 5 MG/ML STERILE SOLUTION IS FOR CLINICAL RESEARCH PURPOSES. IT IS NOT IN THE SCOPE OF 2024/16-19 NOTIFICATION +. | XXXXXXXXXX | 20 | UNIT | 1152 | IRELAND | NA |
3/26/2024 | 300215000000 | MEDICINE-GUSELKUMAB 50 MG 0.5 ML SOLUTION | XXXXXXXXXX | 15 | UNIT | 790 | SWITZERLAND | NA |
3/26/2024 | 300215000000 | ZARZIO 48MIU/0,5ML 5LISY BI O1 TR,ZARZIO 48 MU/0,5ML READY-TO-USE INJECTOR (5 INJECTORS) CONTAINING SOLUTION FOR INJECTION/INFUSION (DRUG FOR HUMANITY) | XXXXXXXXXX | 7010 | UNIT | 365259 | AUSTRIA | NA |
3/25/2024 | 300215000000 | SANDIMMUN 50 MG 10X1 AMPOULES (708499), SANDIMMUN 50 MG/ML CONCENTRATED INFUSION SOLUTION (10 AMPOULES) (+PO NO:1500092441-4700000230) (HOOD DRUG) | XXXXXXXXXX | 1905 | UNIT | 18867 | SWITZERLAND | NA |